The global drug discovery informatics market is projected to reach USD 2.84 Billion in 2022 from USD 1.50 Billion in 2016, at CAGR of 11.2% during forecast period. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022. In the current market scenario, there is a growing demand for discovery informatics solutions.
Click Now for Sample Copy of Drug Discovery Informatics Market spread across 115 Pages, Profiling 15 Companies and Supported with 63 Tables and 24 Figures is now available at www.rnrmarketresearch.com/contacts…ple?rname=1274076 .
Growth in drug discovery informatics market is mainly driven by factors such as rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs.
Drug Discovery Informatics Market, By Function
2 Sequencing & Target Data Analysis
4 Molecular Modelling
5 Libraries & Database Preparation
Drug Discovery Informatics Market, By End User
2 Pharmaceutical and Biotechnology Companies
3 Contract Research Organizations (CROS)
The drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market.
Report at www.rnrmarketresearch.com/contacts/1274076 .
North America is expected to account for the largest share of the global drug discovery informatics market. Asia Pacific is expected to register the highest growth rate from 2017 to 2022.
This can be attributed to the fastest-growing APAC pharmaceutical market in the world, the availability of many qualified researchers, and the low cost of human resources and manufacturing.
- Providers drug discovery informatics solution
- Pharmaceutical companies
- Academic institutes
- Biotechnology companies
- Research institutes
- Government associations
- Contract research organizations (CROs)
Key players in drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the global market.
Drug discovery informatics market in this report is segmented by function, solution, end user, and region. Study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the drug discovery informatics market.
2 Ranking of Players, 2016
3 Competitive Scenario
4 Collaborations, Partnerships, Agreements, & Acquisitions
6 Product Launches & Enhancements
The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.